BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10458236)

  • 1. Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma.
    Apostolidis J; Foran JM; Johnson PW; Norton A; Amess J; Matthews J; Bradburn M; Lister TA; Rohatiner AZ
    J Clin Oncol; 1999 Jan; 17(1):216-21. PubMed ID: 10458236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma.
    Rohatiner AZ; Johnson PW; Price CG; Arnott SJ; Amess JA; Norton AJ; Dorey E; Adams K; Whelan JS; Matthews J
    J Clin Oncol; 1994 Jun; 12(6):1177-84. PubMed ID: 8201380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up.
    Rohatiner AZ; Nadler L; Davies AJ; Apostolidis J; Neuberg D; Matthews J; Gribben JG; Mauch PM; Lister TA; Freedman AS
    J Clin Oncol; 2007 Jun; 25(18):2554-9. PubMed ID: 17515573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin.
    Stein RS; Greer JP; Goodman S; Kallianpur A; Ahmed MS; Wolff SN
    Bone Marrow Transplant; 1999 Feb; 23(3):227-33. PubMed ID: 10084253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.
    Brown JR; Feng Y; Gribben JG; Neuberg D; Fisher DC; Mauch P; Nadler LM; Freedman AS
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1057-65. PubMed ID: 17697968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up.
    Apostolidis J; Gupta RK; Grenzelias D; Johnson PW; Pappa VI; Summers KE; Salam A; Adams K; Norton AJ; Amess JA; Matthews J; Bradburn M; Lister TA; Rohatiner AZ
    J Clin Oncol; 2000 Feb; 18(3):527-36. PubMed ID: 10653868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission.
    Freedman AS; Gribben JG; Neuberg D; Mauch P; Soiffer RJ; Anderson KC; Pandite L; Robertson MJ; Kroon M; Ritz J; Nadler LM
    Blood; 1996 Oct; 88(7):2780-6. PubMed ID: 8839876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
    Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N
    Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
    Freedman AS; Neuberg D; Gribben JG; Mauch P; Soiffer RJ; Fisher DC; Anderson KC; Andersen N; Schlossman R; Kroon M; Ritz J; Aster J; Nadler LM
    J Clin Oncol; 1998 Jan; 16(1):13-8. PubMed ID: 9440717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre.
    Foran JM; Apostolidis J; Papamichael D; Norton AJ; Matthews J; Amess JA; Lister TA; Rohatiner AZ
    Ann Oncol; 1998 Aug; 9(8):865-9. PubMed ID: 9789609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloablative therapy with autologous bone marrow transplantation as consolidation of remission in patients with follicular lymphoma.
    Rohatiner AZ; Price CG; Arnott S; Norton A; Evans ML; Cotter F; Dorey E; Davis CL; Clark P; Sterlini J
    Ann Oncol; 1991 Feb; 2 Suppl 2():147-50. PubMed ID: 2049312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma.
    Freedman AS; Neuberg D; Mauch P; Soiffer RJ; Anderson KC; Fisher DC; Schlossman R; Alyea EP; Takvorian T; Jallow H; Kuhlman C; Ritz J; Nadler LM; Gribben JG
    Blood; 1999 Nov; 94(10):3325-33. PubMed ID: 10552941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphoma.
    Rohatiner AZ; Freedman A; Nadler L; Lim J; Lister TA
    Ann Oncol; 1994; 5 Suppl 2():143-6. PubMed ID: 8204513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma.
    Johnson PW; Price CG; Smith T; Cotter FE; Meerabux J; Rohatiner AZ; Young BD; Lister TA
    J Clin Oncol; 1994 Apr; 12(4):798-805. PubMed ID: 8151322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study.
    Freedman AS; Takvorian T; Neuberg D; Mauch P; Rabinowe SN; Anderson KC; Soiffer RJ; Spector N; Grossbard M; Robertson MJ
    J Clin Oncol; 1993 May; 11(5):931-6. PubMed ID: 8487057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial.
    Horning SJ; Negrin RS; Hoppe RT; Rosenberg SA; Chao NJ; Long GD; Brown BW; Blume KG
    Blood; 2001 Jan; 97(2):404-9. PubMed ID: 11154216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies.
    Friedberg JW; Neuberg D; Gribben JG; Mauch P; Anderson KC; Soiffer RJ; Takvorian T; Fisher DC; Schlossman R; Jallow H; Kuhlman C; Ritz J; Freedman AS
    Biol Blood Marrow Transplant; 1999; 5(4):262-8. PubMed ID: 10465106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation.
    McCowage GB; Vowels MR; Shaw PJ; Lockwood L; Mameghan H
    J Clin Oncol; 1995 Nov; 13(11):2789-95. PubMed ID: 7595740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOP.
    Verdonck LF; Dekker AW; de Gast GC; van Kempen ML; Lokhorst HM; Nieuwenhuis HK
    J Clin Oncol; 1992 Dec; 10(12):1949-54. PubMed ID: 1453209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloablative therapy for follicular lymphoma.
    Rohatiner AZ; Lister TA
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):1003-12. PubMed ID: 1938753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.